FIXX Homology Medicines Inc.

Homology Medicines is an US based genetic medicines company. It is dedicated towards translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases.

$7.30  -0.18 (-2.41%)
As of 04/09/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/28/2018
Outstanding shares:  50,487,649
Average volume:  823,922
Market cap:   $369,569,591
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    438083107
ISIN:        US4380831077
Sedol:      BFMMJ23
Valuation   (See tab for details)
PE ratio:   -2.87
PB ratio:   1.88
PS ratio:   136.78
Return on equity:   -65.66%
Net income %:   -4,762.92%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy